Guardian Pharmacy Services (NYSE:GRDN) Shares Down 3.6% - What's Next?

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report)'s share price traded down 3.6% on Tuesday . The stock traded as low as $22.76 and last traded at $22.80. 17,273 shares traded hands during mid-day trading, a decline of 91% from the average session volume of 187,614 shares. The stock had previously closed at $23.65.

Analysts Set New Price Targets

GRDN has been the subject of a number of analyst reports. Raymond James assumed coverage on Guardian Pharmacy Services in a research note on Monday, October 21st. They issued an "outperform" rating and a $21.00 price target for the company. Truist Financial increased their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a "buy" rating in a research report on Friday, November 15th. Finally, Stephens started coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an "overweight" rating and a $21.00 price target on the stock.

Guardian Pharmacy Services Trading Down 6.4 %

The stock has a 50 day simple moving average of $21.42.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to analysts' expectations of $303.21 million. Analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Insider Transactions at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Steven D. Cosler bought 7,000 shares of Guardian Pharmacy Services stock in a transaction dated Tuesday, November 19th. The shares were purchased at an average cost of $21.22 per share, for a total transaction of $148,540.00. Following the acquisition, the director now directly owns 17,713 shares in the company, valued at approximately $375,869.86. This represents a 65.34 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Thomas J. Salentine, Jr. bought 35,714 shares of the firm's stock in a transaction dated Friday, September 27th. The shares were acquired at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the transaction, the director now directly owns 35,714 shares in the company, valued at approximately $499,996. This represents a ∞ increase in their position. The disclosure for this purchase can be found here.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Franklin Resources Inc. purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth about $8,575,000. Wellington Management Group LLP bought a new position in shares of Guardian Pharmacy Services during the third quarter valued at approximately $8,400,000. Allspring Global Investments Holdings LLC purchased a new stake in shares of Guardian Pharmacy Services in the third quarter worth approximately $5,460,000. Maven Securities LTD bought a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $3,033,000. Finally, Seven Grand Managers LLC purchased a new position in Guardian Pharmacy Services during the 3rd quarter valued at $2,515,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.